Literature DB >> 11231216

Typical semiology of benign childhood epilepsy with centrotemporal spikes (BCECTS).

U Stephani1.   

Abstract

The ILAE (1989) has defined benign childhood epilepsy with centro-temporal spikes (BCECTS) as follows: BCECTS is a syndrome of brief, simple, partial, hemifacial motor seizures, frequently having associated somatosensory symptoms which have a tendency to evolve into generalised tonic clonic seizures (GTCS) [1]. Both seizure types are often related to sleep. Onset occurs between the ages of 3 and 13 years (peak 9-10 years) and recovery occurs before the age of 15-16 years. Genetic predisposition is frequent, and there is a male predominance. The EEG has blunt high-voltage centrotemporal spikes, often followed by slow waves that are activated by sleep and tend to shift or spread from side to side.

Entities:  

Mesh:

Year:  2000        PMID: 11231216

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

1.  Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes.

Authors:  Chunrong Liu; Mei Song; Jiwen Wang
Journal:  Childs Nerv Syst       Date:  2016-03-16       Impact factor: 1.475

2.  Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.

Authors:  Qirui Zhang; Fang Yang; Zheng Hu; Zhiqiang Zhang; Qiang Xu; Mantini Dante; Han Wu; Zhipeng Li; Qian Li; Kai Li; Guangming Lu
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

3.  Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.

Authors:  Johannes R Lemke; Dennis Lal; Eva M Reinthaler; Isabelle Steiner; Michael Nothnagel; Michael Alber; Kirsten Geider; Bodo Laube; Michael Schwake; Katrin Finsterwalder; Andre Franke; Markus Schilhabel; Johanna A Jähn; Hiltrud Muhle; Rainer Boor; Wim Van Paesschen; Roberto Caraballo; Natalio Fejerman; Sarah Weckhuysen; Peter De Jonghe; Jan Larsen; Rikke S Møller; Helle Hjalgrim; Laura Addis; Shan Tang; Elaine Hughes; Deb K Pal; Kadi Veri; Ulvi Vaher; Tiina Talvik; Petia Dimova; Rosa Guerrero López; José M Serratosa; Tarja Linnankivi; Anna-Elina Lehesjoki; Susanne Ruf; Markus Wolff; Sarah Buerki; Gabriele Wohlrab; Judith Kroell; Alexandre N Datta; Barbara Fiedler; Gerhard Kurlemann; Gerhard Kluger; Andreas Hahn; D Edda Haberlandt; Christina Kutzer; Jürgen Sperner; Felicitas Becker; Yvonne G Weber; Martha Feucht; Hannelore Steinböck; Birgit Neophythou; Gabriel M Ronen; Ursula Gruber-Sedlmayr; Julia Geldner; Robert J Harvey; Per Hoffmann; Stefan Herms; Janine Altmüller; Mohammad R Toliat; Holger Thiele; Peter Nürnberg; Christian Wilhelm; Ulrich Stephani; Ingo Helbig; Holger Lerche; Fritz Zimprich; Bernd A Neubauer; Saskia Biskup; Sarah von Spiczak
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

4.  Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy.

Authors:  Qirui Zhang; Fang Yang; Zheng Hu; Qiang Xu; Boris C Bernhardt; Wei Quan; Qian Li; Zhiqiang Zhang; Guangming Lu
Journal:  Front Neurosci       Date:  2018-11-27       Impact factor: 4.677

Review 5.  Sleep Related Epilepsy and Pharmacotherapy: An Insight.

Authors:  Jaya Kumar; Amro Solaiman; Pasuk Mahakkanukrauh; Rashidi Mohamed; Srijit Das
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.